SenoRx, Inc. (NASDAQ:SENO)
CAPS Rating:
The Company develops, manufactures and sells minimally-invasive medical devices for the diagnosis of breast cancer.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
0
MstrGold
(32.51)
Submitted: 6/9/2010 6:49:39 AM :
Start Price:
$7.03
SENO Score:
-13.04
Company is overvalued in terms of fundamental prospects (source Ultralong).
Recs
0
jhe2jhe
(46.95)
Submitted: 9/27/2007 7:01:37 PM :
Start Price:
$8.38
SENO Score:
+16.47
Great startup will do well. Very good business lan in a much needed area with outstanding products
Recs
0
JhansiKiRani
(67.46)
Submitted: 6/27/2007 11:44:42 AM :
Start Price:
$9.83
SENO Score:
-6.45
It's already outeperformed S & P once.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 3 of 3